INTELLIA THERAPEUTICS INC (NTLA) Stock Institutional Trading Activity


INTELLIA THERAPEUTICS INC (NTLA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, ARK Invest, and Viking Global Investors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCBuy1,021,7001,672,700$15,037,573
Q3 2025ARK InvestSell-1,098,69811,919,178$205,844,200
Q3 2025Renaissance Technologies LLCSell-25,900651,000$11,242,770
Q2 2025ARK InvestBuy6,86113,017,876$122,107,675
Q2 2025Renaissance Technologies LLCBuy578,200676,900$6,349,322
Q1 2025ARK InvestBuy474,62913,011,015$92,508,319
Q4 2024ARK InvestBuy280,94612,536,386$146,174,266
Q4 2024Renaissance Technologies LLCBuy60,00098,700$1,150,842
Q3 2024ARK InvestBuy659,65112,255,440$251,849,296
Q2 2024ARK InvestBuy606,50711,595,789$259,513,759
Q2 2024Renaissance Technologies LLCBuy25,30338,700$866,106
Q1 2024ARK InvestSell-423,16710,989,282$302,315,161
Q4 2023ARK InvestBuy1,463,82011,412,449$347,965,557
Q4 2023Renaissance Technologies LLCSell-3,15713,397$408
Q3 2023ARK InvestBuy422,6989,948,629$314,575,638
Q2 2023ARK InvestSell-311,2359,525,931$388,467,484
Q1 2023ARK InvestBuy416,3849,837,166$366,631,177
Q1 2023Renaissance Technologies LLCSell-103,04616,554$617
Q1 2023Viking Global InvestorsSell-451,8651,569,545$58,496,942
Q4 2022ARK InvestSell-236,2709,420,782$328,691,084
Q4 2022Viking Global InvestorsBuy132,3432,021,410$70,526,995
Q3 2022ARK InvestBuy142,4729,657,052$540,409
Q3 2022Viking Global InvestorsSell-339,3161,889,067$105,712
Q2 2022ARK InvestBuy533,5519,514,580$439,003
Q2 2022Renaissance Technologies LLCBuy78,600119,600$6,190
Q2 2022Viking Global InvestorsSell-240,3772,228,383$115,341
Q1 2022ARK InvestBuy1,064,1478,981,029$652,651
Q1 2022Viking Global InvestorsBuy889,2242,468,760$179,405
Q4 2021ARK InvestBuy1,173,3267,916,882$936,092
Q4 2021Viking Global InvestorsBuy300,0051,579,536$186,764

Frequently asked questions about NTLA activity

  • Which institutional owners are buying NTLA?

    Institutional owners buying NTLA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in NTLA activity?

    "Buy" means an investor increased their reported position in NTLA compared to the prior reporting period. This reflects growing exposure to INTELLIA THERAPEUTICS INC (NTLA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in NTLA increasing?

    Institutional interest in NTLA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.